Distribution Deals in Medical Devices 2016-2026
Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Benchmark Global Distribution Partnerships Across the Medical Device Industry
This latest Distribution Deals in Medical Devices report provides a comprehensive analysis of distribution partnerships across the global medical device sector. Designed for business development, licensing, and commercial strategy professionals, the report delivers detailed insight into how companies structure distribution agreements, negotiate financial terms, and expand market access through strategic partnerships.
Fully revised and updated, the report examines distribution deals announced between 2016 and 2026, providing a clear view of how device manufacturers collaborate with distribution partners to reach new markets and accelerate commercialization.
The report contains a comprehensive listing of distribution deals recorded in the Current Agreements deals and alliances database, including financial terms where available and links to online deal records. Where agreements have been publicly filed, the report also provides access to the underlying contract documents submitted to the SEC, enabling deeper insight into how distribution partnerships are structured in practice.
Whether you are benchmarking deal structures, identifying distribution partners, or performing due diligence on commercialization strategies, this report provides the real-world deal data and contract intelligence needed to structure stronger distribution agreements.
Key Benefits
✔ Save Significant Research Time
Access a consolidated database of distribution deals instead of searching multiple press releases, databases, and regulatory filings.
✔ Benchmark Distribution Deal Structures
Understand how medical device companies structure distribution partnerships, including territorial rights, commercialization responsibilities, and operational roles.
✔ Analyze Financial Deal Terms
Review disclosed payment structures and commercial terms to benchmark the financial structure of comparable distribution partnerships.
✔ Access Real Contract Documents
Where available, explore SEC-filed distribution agreements, providing insight into the detailed contractual provisions behind real-world partnerships.
✔ Identify the Most Active Distribution Dealmakers
Discover which companies are leading distribution partnerships across the medical device sector and analyze their commercialization strategies.
✔ Track Industry Trends
Analyze distribution deal activity since 2016 across companies, therapeutic areas, and technology segments to understand how device commercialization strategies are evolving.
What’s Included in the Report
-
Analysis of distribution dealmaking trends since 2016
-
Overview of distribution partnership structures and financial models
-
Review of leading distribution deals by disclosed value
-
Profiles of the most active distribution dealmakers
-
Detailed analysis of deals organized by company, therapeutic area, and technology type
-
A comprehensive directory of distribution deals recorded in the Current Agreements database
-
Links to online deal records and contract documents where available
Due Diligence Insights from Real Agreements
By reviewing actual distribution contracts, the report allows users to evaluate key partnership provisions such as:
-
Territorial distribution rights
-
Commercial responsibilities between partners
-
Payment structures and commercial terms
-
Exclusivity provisions
-
Supply and commercialization obligations
-
Contract duration and termination provisions
Why This Report Matters
Distribution partnerships are critical to the global commercialization of medical devices, enabling companies to expand market reach, accelerate product launches, and access regional expertise.
By combining comprehensive deal data, financial benchmarking, and access to real contract documents, this report provides the intelligence needed to structure stronger distribution partnerships and negotiate more effectively.
Key Benefits
✔ Save Significant Research Time
Access a consolidated database of distribution deals instead of searching multiple press releases, databases, and regulatory filings.
✔ Benchmark Distribution Deal Structures
Understand how medical device companies structure distribution partnerships, including territorial rights, commercialization responsibilities, and operational roles.
✔ Analyze Financial Deal Terms
Review disclosed payment structures and commercial terms to benchmark the financial structure of comparable distribution partnerships.
✔ Access Real Contract Documents
Where available, explore SEC-filed distribution agreements, providing insight into the detailed contractual provisions behind real-world partnerships.
✔ Identify the Most Active Distribution Dealmakers
Discover which companies are leading distribution partnerships across the medical device sector and analyze their commercialization strategies.
✔ Track Industry Trends
Analyze distribution deal activity since 2016 across companies, therapeutic areas, and technology segments to understand how device commercialization strategies are evolving.
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Trends in distribution dealmaking
2.1. Introduction
2.2. Definition of distribution deal
2.3. Trends in distribution deals since 2016
2.3.1. Distribution dealmaking by year
2.3.2. Distribution dealmaking by phase of development
2.3.3. Distribution dealmaking by therapy area
2.3.4. Distribution dealmaking by technology type
2.3.5. Distribution dealmaking by most active company
2.3.6 Attributes of pure distribution deals
2.3.7 Attributes of distribution in multi-component deals
2.4. Aligning partners to make the distribution agreement work
Chapter 3 – Overview of distribution deal structure
3.1. Introduction
3.2. Distribution agreement structure
3.3 Distribution rights as part of a wider alliance agreement
Chapter 4 – Leading distribution deals
4.1. Introduction
4.2. Top distribution deals by value
Chapter 5 – Top 25 most active distribution dealmakers
5.1. Introduction
5.2. Top 25 most active distribution dealmakers
Deal directory
Deal directory – distribution dealmaking by companies A-Z
Deal directory – distribution dealmaking by therapy area
Deal directory – distribution dealmaking by technology type
About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering
TABLE OF FIGURES
Figure 1: Definition of distribution
Figure 2: Trends in distribution deal announcements
Figure 3: Distribution deals signed at each phase of development
Figure 4: Distribution deals by therapy area
Figure 5: Distribution deals by technology type
Figure 6: Top 25 most active distribution dealmakers
Figure 7: Issues in implementing distribution agreements
Figure 8: Distribution agreements – what should a contract include?
Figure 9: Components of the distribution deal structure
Figure 10: Top distribution deals by value
Figure 11: Most active distribution dealmakers
Pricing options
- $3,995: single-user (encrypted file - one user/device)
- $5,995: multi-user (encrypted file - up to 5 users/devices)
- $7,995: company (unencrypted file)
Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin PDF Reader will be provided at report delivery.
Company license files are not encrypted and can be accessed using a PDF Reader.
A full explanation of license type definitions can be found here.
Our guarantee
Price promise
We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.
Delivery Deadline
We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)
Latest report
If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.
Serious Security
We take your data and security seriously. See our privacy policy for details of how we manage your data.
Sales Support
If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.
- Total Trust
Current Partnering is part of Biopharma Research Ltd based in County Durham, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.
Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.
The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant
Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.


